ETR:SHL Siemens Healthineers (SHL) Stock Forecast, Price & News €45.83 +1.19 (+2.67%) (As of 09/20/2023 ET) Add Compare Share Share Today's Range€44.75▼€45.8650-Day Range€44.64▼€53.5052-Week Range€40.32▼€58.08Volume518,505 shsAverage VolumeN/AMarket Capitalization$51.33 billionP/E Ratio32.97Dividend Yield2.07%Price Target€59.74 ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesProfileAnalyst RatingsChartCompetitorsHeadlines Siemens Healthineers MarketRank™ ForecastAnalyst Rating0.00 Rating ScoreUpside/Downside30.4% Upside€59.74 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.55 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €59.74, Siemens Healthineers has a forecasted upside of 30.4% from its current price of €45.83.Amount of Analyst CoverageSiemens Healthineers has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SHL. Previous Next 1.7 Dividend Strength Dividend YieldSiemens Healthineers pays a meaningful dividend of 2.13%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSiemens Healthineers does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Siemens Healthineers is 68.35%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SHL. Previous Next 0.6 News and Social Media Coverage Search Interest1 people have searched for SHL on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Siemens Healthineers insiders have not sold or bought any company stock.Percentage Held by Insiders75.36% of the stock of Siemens Healthineers is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.89% of the stock of Siemens Healthineers is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Siemens Healthineers is 32.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.50.Price to Earnings Ratio vs. SectorThe P/E ratio of Siemens Healthineers is 32.97, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 114.47.Price to Earnings Growth RatioSiemens Healthineers has a PEG Ratio of 2.70. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSiemens Healthineers has a P/B Ratio of 2.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Siemens Healthineers (ETR:SHL) StockSiemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. Siemens Healthineers AG has a collaboration with Oncimmune Holdings plc. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.Read More SHL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHL Stock News HeadlinesJuly 25, 2023 | finance.yahoo.comA Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCareJune 29, 2023 | finance.yahoo.comAre Investors Undervaluing Siemens Healthineers AG (ETR:SHL) By 21%?September 21, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...June 13, 2023 | reuters.comSiemens Healthineers: A breakthrough in cancer treatmentJune 8, 2023 | msn.comREDBURN LIMITED Maintains Siemens Healthineers (FWB:SHL) Buy RecommendationJune 8, 2023 | msn.comBERENBERG Maintains Siemens Healthineers (FWB:SHL) Buy RecommendationMay 12, 2023 | msn.comDTG and SHL: Analysts say BUY These Two DAX 40 SharesMay 12, 2023 | marketwatch.comCloud-Computing In Healthcare Market Prospects, Size, Share, Demand and Current Trends Analysis Till 2027September 21, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.April 26, 2023 | msn.comThe first MRI dedicated to radiotherapy simulation in Romania and in the region, MAGNETOM Sola RT from Siemens Healthineers portfolio, is now available at Amethyst radiotherapy ...April 19, 2023 | msn.comSiemens Healthineers inaugurates MRI facility at BengaluruApril 12, 2023 | benzinga.comSiemens and Microsoft drive industrial productivity with generative artificial intelligenceApril 4, 2023 | finance.yahoo.comRS Abdi Waluyo acquires the world's first photon-counting CT to improve clinical outcomes for patients in IndonesiaFebruary 9, 2023 | finance.yahoo.comSiemens Healthineers AG's (ETR:SHL) CEO Compensation Is Looking A Bit Stretched At The MomentDecember 18, 2022 | marketwatch.comMedical Telemonitoring System Market : Analysis, Forecast, Size, New Trends and Insights, Update, COVID-19 ImpactNovember 27, 2022 | yahoo.comSiemens Healthineers' (ETR:SHL) Dividend Will Be Increased To €0.95November 21, 2022 | finance.yahoo.comSiemens Healthineers AG's (ETR:SHL) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?November 9, 2022 | msn.comSiemens Healthineers 4Q Net Pft EUR636MOctober 31, 2022 | finance.yahoo.comSiemens Healthineers and University of Miami Health System Enter Value Partnership Agreement to Transform HealthcareMay 24, 2022 | finance.yahoo.comPrecisionOS Partners with Siemens Healthineers for VR-based Surgical Training DevelopmentApril 25, 2022 | marketwatch.comCloud-Computing In Healthcare Market Trends Growth opportunities & Revenue Growth by the end of 2027January 26, 2022 | nz.finance.yahoo.comSiemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.January 21, 2022 | investing.comSiemens Healthineers AG (SHLG)November 15, 2021 | benzinga.comSiemens Healthineers Proud to be Recognized in a Study Conducted by the Foundation for the National Institutes of HealthOctober 26, 2021 | finance.yahoo.comSiemens Healthineers AG (SHL.F)October 21, 2021 | finance.yahoo.comSiemens Healthineers AG (SHL.DE)August 17, 2021 | finance.yahoo.comSyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens HealthineersSee More Headlines Receive SHL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolETR:SHL CUSIPN/A CIKN/A Webwww.healthcare.siemens.de Phone49 69 6682 6602FaxN/AEmployees70,800Year FoundedN/APrice Target and Rating Average Stock Price Forecast€59.74 High Stock Price Forecast€67.20 Low Stock Price Forecast€49.00 Forecasted Upside/Downside+30.4%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)€1.39 Trailing P/E Ratio32.97 Forward P/E Ratio17.49 P/E Growth2.7Net Income$1.60 billion Net Margins7.41% Pretax MarginN/A Return on Equity9.11% Return on Assets2.94% Debt Debt-to-Equity Ratio97.36 Current Ratio0.97 Quick Ratio0.71 Sales & Book Value Annual Sales$21.62 billion Price / Sales2.37 Cash Flow€1.18 per share Price / Cash Flow38.96 Book Value€15.45 per share Price / Book2.97Miscellaneous Outstanding Shares1,120,000,000Free FloatN/AMarket Cap$51.33 billion OptionableNot Optionable Beta0.67 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Bernhard Montag (Age 54)Pres, CEO & Chairman of Management Board Comp: $3.23MDr. Jochen Schmitz Ph.D. (Age 57)CFO & Member of Management Board Comp: $1.91MMs. Darleen Caron (Age 59)Chief HR Officer, Labor Director & Member of Management Board Comp: $1.61MMs. Elisabeth Staudinger-Leibrecht (Age 53)Member of Management Board Comp: $1.15MMr. Peter Koerte Ph.D.Chief Technology & Strategy OfficerMr. Marc KoebernickHead of Investor RelationsChristian KlaussnerExec. VP of Fin.Andre HartungHead of ImagingCarsten BertramHead of Advanced TherapiesBernd OhnesorgeHead of Europe, Middle East & AfricaMore ExecutivesKey CompetitorsBayer AktiengesellschaftETR:BAYNMerck KGaAETR:MRKStratecETR:SBSDrägerwerk AG & Co. KGaAETR:DRW3Fresenius Medical Care AG & Co. KGaAETR:FMEView All Competitors SHL Stock - Frequently Asked Questions What is Siemens Healthineers' stock price forecast for 2023? 0 Wall Street research analysts have issued 1 year price objectives for Siemens Healthineers' shares. Their SHL share price forecasts range from €49.00 to €67.20. On average, they anticipate the company's stock price to reach €59.74 in the next year. This suggests a possible upside of 30.4% from the stock's current price. View analysts price targets for SHL or view top-rated stocks among Wall Street analysts. How have SHL shares performed in 2023? Siemens Healthineers' stock was trading at €46.73 at the beginning of the year. Since then, SHL shares have decreased by 1.9% and is now trading at €45.83. View the best growth stocks for 2023 here. Is Siemens Healthineers a good dividend stock? Siemens Healthineers (ETR:SHL) pays an annual dividend of €0.95 per share and currently has a dividend yield of 2.13%. The dividend payout ratio is 68.35%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of Siemens Healthineers own? Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT). What is Siemens Healthineers' stock symbol? Siemens Healthineers trades on the ETR under the ticker symbol "SHL." What is Siemens Healthineers' stock price today? One share of SHL stock can currently be purchased for approximately €45.83. How much money does Siemens Healthineers make? Siemens Healthineers (ETR:SHL) has a market capitalization of $51.33 billion and generates $21.62 billion in revenue each year. The company earns $1.60 billion in net income (profit) each year or €1.39 on an earnings per share basis. How many employees does Siemens Healthineers have? The company employs 70,800 workers across the globe. How can I contact Siemens Healthineers? Siemens Healthineers' mailing address is Henkestrasse 127, Erlangen 91052, Germany. The official website for the company is www.healthcare.siemens.de. The company can be reached via phone at 49 69 6682 6602. This page (ETR:SHL) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siemens Healthineers AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.